Project Details
Description
Efficacy evaluation of a CRACM1 inhibitor, Ro2959, in a hu scid mouse xenogenic graft versus host disease model
| Status | Finished |
|---|---|
| Effective start/end date | 11/29/10 → 11/28/11 |
Funding
- HOFFMANN-LA ROCHE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.